Appointment booking for Dr. Saul Eisenstat, MD is currently not available.Dr. Saul Eisenstat, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Saul Eisenstat, MD (he/him) is a Surgeon in Mountain View, CA with over 18 years of experience. What is your opinion of Dr. Saul Eisenstat, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Saul Eisenstat, MD has received over $3,799 which includes payments from the following companies:
$1,020.64 from Davol Inc.
$461.62 from Janssen Pharmaceuticals, Inc
$281.95 from Novartis Pharmaceuticals Corporation
$227.54 from Celgene Corporation
$226.49 from Janssen Biotech, Inc.
$187.86 from Novo Nordisk Inc
$157.31 from AbbVie, Inc.
$136.02 from Ethicon US, LLC
$120.72 from Amgen Inc.
$120.23 from Mallinckrodt LLC
$80.48 from Bayer HealthCare Pharmaceuticals Inc.
$67.28 from Sanofi Pasteur Inc.
$65.26 from GlaxoSmithKline, LLC.
$60.32 from Prometheus Laboratories Inc.
$54.64 from CooperSurgical, Inc.
$48.08 from Pharmacyclics LLC, An AbbVie Company
$43.90 from EMD Serono, Inc.
$37.51 from Daiichi Sankyo Inc.
$37.42 from Astellas Pharma US Inc
$35.21 from AstraZeneca Pharmaceuticals LP
Payments received by Dr. Saul Eisenstat, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!